Abstract
Genetic nephropathies represent a challenging class of disorders to be treated by gene therapy. This is primarily due to the filtering properties of the kidney itself, which does not allow the vehicle carrying the transgene of interest to remain long enough in the organ to penetrate efficiently into the nephrotic cells. Also, the kidney has a complex anatomical structure composed of different cell types compartmentalized within isolated anatomic structures that limit their access. Here, we describe a simple surgical procedure to deliver recombinant adeno-associated virus (rAAV) to the whole kidney based on the hydraulic force of the retrograde renal vein injection. In its clinical form, this procedure would correspond to a renal venography where a catheter is threaded retrograde from the femoral vein under fluoroscopic guidance.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Devuyst O, Knoers NV, Remuzzi G et al (2014) Rare inherited kidney diseases: challenges, opportunities, and perspectives. Lancet 383(9931):1844–1859
Knoll G (2008) Trends in kidney transplantation over the past decade. Drugs 68(Suppl 1):3–10
Davis CL, Delmonico FL (2005) Living-donor kidney transplantation: a review of the current practices for the live donor. J Am Soc Nephrol 16(7):2098–2110
Cecka JM (2008) Kidney transplantation in the United States. Clin Transpl 1–18
Rocca CJ, Ur SN, Harrison F et al (2014) rAAV9 combined with renal vein injection is optimal for kidney-targeted gene delivery: conclusion of a comparative study. Gene Ther 21(6):618–628
Beckmann CF, Abrams HL (1980) Renal venography: anatomy, technique, applications, analysis of 132 venograms, and a review of the literature. Cardiovasc Intervent Radiol 3(1):45–70
Maruyama H, Hiquchi N, Nishikawa Y et al (2002) Kidney-targeted naked DNA transfer by retrograde renal vein injection in rats. Hum Gene Ther 13(3):455–468
Chetboul V, Klonjkowski B, Lefebvre HP et al (2001) Short-term efficiency and safety of gene delivery into canine kidneys. Nephrol Dial Transplant 16(3):608–614
Lipkowitz MS, Hanss B, Tulchin N et al (1999) Transduction of renal cells in vitro and in vivo by adeno-associated virus gene therapy vectors. J Am Soc Nephrol 10(9):1908–1915
Chen S, Agarwal A, Glushakova OY et al (2003) Gene delivery in renal tubular epithelial cells using recombinant adeno-associated viral vectors. J Am Soc Nephrol 14(4):947–958
Takeda S, Takahashi M, Mizukami H et al (2004) Successful gene transfer using adeno-associated virus vectors into the kidney: comparison among adeno-associated virus serotype 1-5 vectors in vitro and in vivo. Nephron Exp Nephrol 96(4):e119–e126
Qi YF, Li QH, Shenoy V et al (2013) Comparison of the transduction efficiency of tyrosine-mutant adeno-associated virus serotype vectors in kidney. Clin Exp Pharmacol Physiol 40(1):53–55
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Rocca, C.J., Cherqui, S. (2019). Gene Transfer to Mouse Kidney In Vivo. In: Manfredsson, F., Benskey, M. (eds) Viral Vectors for Gene Therapy. Methods in Molecular Biology, vol 1937. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-9065-8_14
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9065-8_14
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-9064-1
Online ISBN: 978-1-4939-9065-8
eBook Packages: Springer Protocols